ORIGINAL RESEARCH Volume Overload Adverse Outcomes Chronic Kidney Disease Clinical Observational Animal Studies SzuChun Hung MD YiShin Lai MS KoLin Kuo MD PhD DerCherng Tarng MD PhD BackgroundVolume overload frequently encountered associated cardiovascular risk factors patients chronic kidney disease CKD However relationship volume overload adverse outcomes CKD fully understood Methods ResultsA prospective cohort 338 patients stage 3 5 CKD followed median 21 years The study participants stratiﬁed presence absence volume overload deﬁned overhydration index assessed bioimpedance spectroscopy exceeding 7 90th percentile healthy population The primary outcome composite estimated glomerular ﬁltration rate decline 50 endstage renal disease The secondary outcome included composite morbidity mortality cardiovascular causes Animal models simulate ﬂuid retention observed human CKD We patients volume overload higher risk primary secondary end points adjusted Cox models Furthermore overhydration appears important hypertension predicting elevated risk In rats subjected unilateral nephrectomy highsalt diet extracellular water signiﬁcantly increased This ﬂuid retention associated increase blood pressure proteinuria renal inﬂammation macrophage inﬁltration tumor necrosis factora overexpression glomerular sclerosis cardiac ﬁbrosis Diuretic treatment indapamide attenuated changes suggesting ﬂuid retention play role development adverse outcomes ConclusionsVolume overload contributes CKD progression cardiovascular diseases Further research warranted J Am Heart Assoc 20154 clarify correction volume overload improve outcomes CKD patients e001918 doi 101161JAHA115001918 Key Words bioimpedance cid129 cardiovascular disease cid129 chronic kidney disease cid129 hypertension cid129 overhydration cid129 volume overload C hronic kidney disease CKD increasingly recognized public health problem worldwide1 CKD substantially increases risks endstage renal disease ESRD cardiovascular disease CVD associated consid erable healthcare costs2 There convincing evidence development ESRD CVD delayed multidisciplinary approach controls modiﬁable risk factors34 We previously demonstrated volume overload From Division Nephrology Taipei Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation New Taipei City Taiwan SCH KLK School Medicine Tzu Chi University Hualien Taiwan SCH KLK Institute Physiology National YangMing University Taipei Taiwan YSL DCT Division Nephrology Department Medicine Taipei Veterans General Hospital Taipei Taiwan DCT Correspondence DerCherng Tarng MD PhD Division Nephrology Department Medicine Taipei Veterans General Hospital No 201 Section 2 ShihPai Road Taipei 11217 Taiwan Email dctarngvghtpegovtw Received February 12 2015 accepted April 3 2015 ª 2015 The Authors Published behalf American Heart Association Inc Wiley Blackwell This open access article terms Creative Commons AttributionNonCommercial License permits use distribution reproduction medium provided original work properly cited commercial purposes common CKD patients associated anemia hypertension proteinuria arterial stiffness inﬂamma tion56 strong predictors CKD progression CVD events Consequently volume overload shows great promise potential modiﬁable risk factor Volume overload linked increased morbidity mortality patients undergoing longterm hemodialysis patients acute kidney injury78 However available evidence detailing effects volume overload CKD patients use valid technique measuring level ﬂuid status values obtained compared directly values normal population Few studies conducted evaluate association volume overload adverse outcomes patients nondialysisdependent CKD9 fewer conducted animal models We hypothesized volume overload contribute signiﬁcantly development adverse clinical outcomes patients nondialysisdependent CKD In present study examined association volume overload renal cardiovascular outcomes 338 adult patients stage 3 5 CKD Body Composition Monitor DOI 101161JAHA115001918 Journal American Heart Association 1 O R I G I N A L R E S E A R C H Volume Overload CKD Outcomes Hung et al BCM Fresenius Medical Care Bad Homburg Germany novel bioimpedance spectroscopy device measure volume status Furthermore examined effect high saltinduced ﬂuid retention renal cardiac damage uninephrectomized rats This animal model closely simulates volume overload observed human CKD provides opportunities investigate causality diseasespeciﬁc mechanisms Materials Methods Patients Laboratory Measurements The study design population previously described6 Brieﬂy 338 patients stage 3 5 CKD referred nephrology clinic Taipei Tzu Chi Hospital Taiwan September 1 2011 December 31 2012 enrolled study followed June 30 2014 In patients thorough medical history taken medical chart reviewed time study enrollment Diabetes mellitus assumed present patients reported current past use insulin andor oral antidiabetic agents Hypertension deﬁned basis blood pressure BP 14090 mm Hg current therapy hypertension The presence CVD deﬁned medical history clinical ﬁndings congestive heart failure coronary artery disease documented coronary angiography history myocardial infarction andor cerebrovascular disease The primary outcome ﬁrst occurrence decline estimated glomerular ﬁltration rate eGFR 50 ESRD needing chronic dialysis The secondary outcome morbidity mortality cardiovascular ﬁrst occurrence causes composite myocardial infarction hospitalization congestive heart failure unstable angina death cardiovascular causes Changes eGFR conﬁrmed 4 weeks treatment potentially reversible factors initiation chronic dialysis The timing determined according regulations National Health Insurance Administration Taiwan CVD deaths included fatal myocardial infarction congestive heart failure arrhythmia sudden death The patients followed 3 months For primary outcome patients censored time outpatient visit death end followup period secondary outcome patients censored time outpatient visit noncardiovascular death end followup period The study protocol approved Institutional Review Board Taipei Tzu Chi Hospital Informed consent obtained participants study complies Declaration Helsinki BP measured use automated oscillometric sphygmomanometry Welch Allyn Series 300 All study select personnel trained use device appropriately sized arm cuff start measurements 10 minutes rest subject having voided seated quietly straightback chair arm heart level The plasma levels interleukin 6 IL6 tumor necrosis factor TNFa RD Systems Nterminal pro brain natriuretic peptide NTproBNP Roche Diagnostics measured commercially available ELISA kits according manufacturers instructions The serum albumin level determined bromocresol purple BCP assay Proteinuria expressed ratio urine protein creatinine UPCR determined ﬁrst morning void Measurement Human Volume Status The ﬂuid status assessed BCM represented level overhydration OH The BCM measures electrical responses 50 different frequencies 5 1000 kHz OH derived impedance data based unique 3compartment model OH lean tissue mass adipose tissue mass10 OH difference extracellular water ECW tissue detected BCM ECW tissue predicted physiological models normal euvolemic conditions Therefore OH value obtained BCM compared directly value normal population Volume overload deﬁned relative OH value OH normalized ECW OHECW 7 corresponds value 90th percentile healthy population11 The reference range OH validated Taiwanese individuals6 The investigators participants blinded OH results Animals Laboratory Measurements Because clinical observations represent causality animal models simulate elucidate volume overload observed human CKD Threeweekold male SpragueDawley rats n40 randomly assigned receive sham operation uninephrectomy anesthetized pentobarbital 50 mgkg IP subjected normalsalt 04 highsalt 80 diet 4 8 weeks age The saltloaded uninephrectomized rats treated indapamide IDP 3 mgkg day orally investigate role volume overload exacerbating cardiac renal injury CKD Five different experimental groups created sham operated rats raised normal ShamNS highsalt diet ShamHS uninephrectomized rats raised normal UNXNS highsalt diet UNXHS IDPtreated UNXHS rats UNXHSIDP All rats housed room DOI 101161JAHA115001918 Journal American Heart Association 2 O R I G I N A L R E S E A R C H Volume Overload CKD Outcomes Hung et al maintained 21 23C 12hour lightdark cycle provided food water ad libitum All rats placed metabolic cages 24 hours food water consumption urine volume urine sodium protein creatinine levels measured baseline 4 weeks different salt intake At end experiment rats killed decapitation serum kidneys hearts collected The kidney heart samples ﬁxed 10 formalin solution embedded parafﬁn histological analysis The harvested kidney heart tissues frozen liquid nitrogen stored cid180C protein isolation All animal studies performed protocol approved ethics committees animal research Faculty Medicine National YangMing University Systolic BP SBP measured tailcuff method NIBP06 Singa Technology Corporation Conscious rats restrainers habituation 10 15 minutes prior readings taken The serum levels TNFa RD Systems measured commercially available ELISA kits according manufacturers instructions Frozen renal samples homogenized 1 mL01 g kidney tissues sonicated homogenizing buffer The homog enate centrifuged remove tissue debris The supernatant aliquoted stored cid120C An ELISA performed assess TNFa BD Biosciences Proteinuria expressed UPCR For morphological evaluations parafﬁnized kidney sections 3lm thickness stained periodic acidSchiff PAS reagents SigmaAldrich analyzed semiquantitatively severity glomeruloscle rosis described previously Glomerulosclerosis graded scale 0 4 0 indicating normal 1 indicating 1 25 glomeruli sclerotic lesions 2 indicating 26 50 glomeruli sclerotic lesions 3 indicating 51 75 4 indicating 75 sclerotic glomeruli In similar manner cardiac ﬁbrosis scored conditions Masson trichromestained SigmaAldrich sections The blue region section represented collagenenriched areas cellular elements stained red Highpower ﬁelds magniﬁcation 9400 selected randomly digitalized video camera software ImagePro PLUS version 60 subsequently compute percentage bluestained region total area ED1 AbD Serotec immunostaining marker rat macrophages renal tissues The inﬁltration macrophages assessed counting ED1positive cells 10 15 randomly selected cortical ﬁelds magniﬁcation 9400 Measurement Animal Volume Status The ImpediVet ImpediMed analyzes wholebody bioimped ance data determine total body water TBW ECW The ECWTBW taken measure volume status Brieﬂy rats anesthetized measured length weight The animal placed prone position shaved allow adequate skin contact sites needle placement Four needles 25 gauge 9 25 mm bent 90 5 mm tip inserted skin base tail intercept ears longitudinal midline 2 cm sites tip tail nose The measurements initiated leads attached needles Volume status measured baseline end experiment Statistical Analysis All variables expressed frequencies percentages categorical data meancid3SD values medians interquartile ranges continuous data normal distribution respectively Differences 2 groups compared v2 test categorical variables unpaired t test MannWhitney U test continuous variables Differences 2 groups compared v2 statistics 1way 2way ANOVA followed appropriate posthoc tests KruskalWallis test appropriate Cumulative survival curves composite outcome generated KaplanMeier method Cox proportional hazards modeling estimate hazard ratios HRs unadjusted minimally adjusted age sex multivariable adjusted models age sex CVD diabetes mellitus SBP use angiotensinconvert ing enzyme inhibitorsangiotensin II receptor blockers eGFR UPCR cut 05 border microal buminuria macroalbuminuria Because event rate relatively low avoided overﬁtting model selecting 8 covariates multivariable adjustments12 Furthermore adjust related covariates NTproBNP serum albumin strong correlation ﬂuid retention The proportional hazard assumption constant HR time assessed comparing estimated loglog survival curves timeindepen dent covariates All assessed loglog survival plots graphically showed 2 parallel lines indicating violation assumption A 2tailed P value 005 considered statistically signiﬁcant The analyses performed SPSS version 200 SPSS Inc Results Patients Primary outcome The baseline characteristics patients divided based absence presence volume overload presented DOI 101161JAHA115001918 Journal American Heart Association 3 Volume Overload CKD Outcomes Hung et al Table 1 During median follow 21 years 78 patients volumeoverload group 446 reached primary end point compared 22 euvolemia group 135 In addition 71 patients 21 progressed ESRD needing chronic dialysis The decline eGFR patients volume overload signiﬁcantly faster volume overload eGFR slope cid143 cid1126 12 versus cid117 cid178 27 mLmin 173 m2 year respectively P005 KaplanMeier survival analysis showed signiﬁcantly higher CKD progression ESRD patients volume overload P0001 logrank test In multivariable regression analysis Table 2 patients volume overload greater double risk composite end point adjusted HR 245 95 conﬁdence interval CI 145 413 P0001 To elucidate contribution elevated OH levels performed multivariable Cox analyses OH continuous variable These analyses conﬁrmed increased risk composite end point adjusted HR 126 95 CI 112 142 P0001 1L increase OH O R I G I N A L R E S E A R C H Secondary outcome Volume overload similar predictive effect cardiovas cular morbidity mortality Table 2 Fortyseven patients reached secondary end point 40 volumeoverload group 229 7 euvolemia group 43 Thirteen patients died cardiovascular causes 11 volume overload group 63 2 euvolemia group 12 The rate ﬁrst hospitalization congestive heart failure signiﬁcantly higher volumeoverload group 24 patients 137 compared 2 euvolemia group 12 There signiﬁcant difference number coronary events volumeoverload group 13 patients 74 compared 5 euvolemia group 31 Overhydration hypertension outcomes The patients classiﬁed according baseline SBP categories 140 140 mm Hg OH categories 7 7 investigate volume overload higher Table 1 Comparisons CKD Patients With Without Volume Overload Characteristics OH ECWTBW NTproBNP ngL Age y Male sex n Smoking history n DM n CVD n SBP mm Hg Diuretics n RAS blockers n Statins n baPWV ms BMI kgm2 eGFR mLmin 173 m2 UPCR gg Serum sodium meqL Albumin gdL IL6 pgmL TNFa pgmL Total n338 83cid386 472cid333 Euvolemia n163 13cid339 449cid324 2417 779 7713 657cid3135 1120 460 2805 650cid3142 Volume Overload n175 149cid362 493cid327 5307 1774 12750 664cid3128 233 689 71 210 153 453 79 234 138cid317 113 334 200 592 87 257 159cid330 258cid343 287cid3150 111 681 32 196 45 276 23 141 133cid315 42 258 95 583 37 227 151cid328 257cid341 315cid3148 122 697 39 223 108 617 56 32 142cid318 71 406 105 60 50 286 162cid328 261cid343 261cid3147 092 031 245 1364cid341 36cid304 049 022 126 1356cid342 38cid303 167 062 419 1370cid330 34cid304 355 208 613 287 164 459 428 262 833 673 469 942 563 413 807 796 537 1034 P Value 0001 0001 0001 032 075 055 0001 0001 0001 0004 075 022 0001 046 0001 0001 0001 0001 0001 0001 baPWV indicates brachialankle pulse wave velocity BMI body mass index CKD chronic kidney disease CVD cardiovascular disease DM diabetes mellitus ECW extracellular water eGFR estimated glomerular ﬁltration rate IL6 interleukin6 MDRD modiﬁcation diet renal disease NTproBNP Nterminal probrain natriuretic peptide OH overhydration RAS reninangiotensin SBP systolic blood pressure TBW total body water TNFa tumor necrosis factor UPCR urine proteincreatinine ratio Comparison euvolemia volume overload eGFR calculated MDRD equation DOI 101161JAHA115001918 Journal American Heart Association 4 Volume Overload CKD Outcomes Hung et al Table 2 HRs Renal Cardiovascular Outcomes Categorical Continuous Measure OH Unadjusted OH Primary outcome eGFR decline 50 chronic dialysis HR 95 CI Model 1 HR 95 CI Model 2 HR 95 CI Model 3 HR 95 CI 7 vs 7 1 L increase 433 269 697 456 283 736 363 220 599 244 144 413 129 119 139 134 123 145 126 114 139 125 111 141 Secondary outcome cardiovascular morbidity mortality 7 vs 7 1 L increase 637 285 1423 622 278 1392 128 115 143 142 125 162 384 168 876 128 109 150 271 114 648 125 104 151 Model 1 adjusted age sex Model 2 adjusted model 1 variables cardiovascular disease diabetes mellitus systolic blood pressure use angiotensin converting enzyme inhibitorsangiotensin II receptor blockers Model 3 adjusted model 2 variables eGFR urine proteincreatinine ratio cutoff value 05 eGFR indicates estimated glomerular ﬁltration rate HR hazard ratio OH overhydration P0001 P005 O R I G I N A L R E S E A R C H predictive value increased risk composite outcome hypertension The following 4 groups identiﬁed patients normohydrated normoten sive 32 patients hypertensive despite normohydrated 17 nonvolumedependent hypertension patients normotensive despite volume overloaded 22 patients volume overloaded hypertensive 29 volumedependent hyper tension Table 3 Figure 1 KaplanMeier analyses revealed signiﬁcant association volume overload primary secondary outcome P0001 logrank test Figure 2 By multivariable regression analysis risk primary secondary outcome patients volume dependent hypertension signiﬁcantly greater compared patients normohydrated normotensive In contrast patients nonvolumedependent hypertension compared patients normohydrated normotensive Table 4 HR signiﬁcant statistically Animals Fluid retention hypertension proteinuria At baseline signiﬁcant difference 5 groups At 4 weeks water intake urine output urine sodium excretion signiﬁcantly higher rats receiving highsalt diet Figure 3A 3C Consistent expectations UNXHS rats signiﬁcantly higher ratio ECWTBW SBP proteinuria rats ShamNS ShamHS UNXNS control suggesting animal models CKD particularly salt sensitive Diuretic treatment IDP UNXHSIDP signif icantly reduced ECWTBW SBP proteinuria UNXHS rats Figure 3D 3F What changes proteinuria intriguing signiﬁcantly correlated SBP changes The results animal study 4 weeks shown Table 5 Systemic renal inﬂammation At 4 weeks serum renal levels TNFa higher UNXHS rats control rats ShamNS ShamHS UNXNS Diuretic treatment IDP blunted increase inﬂammatory mediator Figure 4A 4B The UNXHS rats marked increase renal macrophage inﬁltrations compared control rats ShamNS ShamHS UNXNS This increase prevented IDP Figure 5A 5B Renal glomerular sclerosis cardiac interstitial ﬁbrosis Glomerular sclerosis increased UNXHS rats compared control rats ShamNS ShamHS UNXNS 4 weeks reduced diuretic treatment IDP Figure 5C 5D Cardiac interstitial ﬁbrosis increased UNXHS rats compared control rats ShamNS ShamHS UNXNS 4 weeks improved IDP Figure 5E 5F Discussion In prospective cohort patients stage 3 5 CKD determined volume overload independently correlated renal cardiovascular outcomes In addi tion patients volumedependent hypertension substantially higher risk adverse outcomes patients nonvolumedependent hypertension Fluid retention appears important hypertension higher predictive value elevated risk We demonstrated reduction renal mass unilateral DOI 101161JAHA115001918 Journal American Heart Association 5 O R I G I N A L R E S E A R C H Volume Overload CKD Outcomes Hung et al Table 3 Characteristics CKD Patients Classiﬁed According Presence Absence Hypertension SBP 140 140 mm Hg Volume Overload OH 7 7 Characteristics SBP mm Hg OH Age y Male sex n DM n CVD n Diuretics n RAS blockers n Statins n baPWV ms BMI kgm2 NTproBNP ngL Serum sodium meqL eGFR mLmin 173 m2 UPCR gg Albumin gdL IL6 pgmL TNFa pgmL SBP 140 OH 7 n105 125cid39 12cid337 63cid315 SBP 140 OH 7 n58 149cid311 15cid343 69cid312 SBP 140 OH 7 n76 126cid310 132cid343 68cid312 SBP 140 OH 7 n99 155cid313 161cid371 66cid313 75 71 26 25 13 12 26 25 62 59 25 24 146cid325 252cid341 36 62 19 33 10 17 16 28 33 57 12 21 167cid337 264cid344 55 72 51 67 27 36 30 40 44 58 24 32 159cid326 258cid341 66 67 57 58 29 29 41 41 61 62 26 26 170cid329 262cid344 85 38 224 136cid34 311cid3160 04 02 10 38cid303 142 68 515 135cid34 288cid3154 07 03 16 37cid304 336 90 1013 137cid34 268cid3152 10 04 26 35cid304 610 277 1712 137cid34 234cid3145 26 10 45 34cid304 27 15 42 30 17 49 44 31 92 42 26 71 55 38 77 61 43 90 79 50 108 80 57 103 P Value 0001 0001 001 053 0001 0001 004 094 050 0001 026 0001 0008 0004 0001 0001 0001 0001 baPWV indicates brachialankle pulse wave velocity BMI body mass index CKD chronic kidney disease CVD cardiovascular disease DM diabetes mellitus eGFR estimated glomerular ﬁltration rate IL6 interleukin6 NTproBNP Nterminal probrain natriuretic peptide OH overhydration RAS reninangiotensin SBP systolic blood pressure TNFa tumor necrosis factor UPCR urine proteincreatinine ratio nephrectomy highsalt intake rats caused increased ECW volume hypertension renal cardiac injury including proteinuria glomerular sclerosis renal macrophage inﬁltrations cardiac interstitial ﬁbrosis Diuretic treatment IDP decreased ﬂuid retention BP led decrease renal cardiac injury The results study suggest natriuresis play important role prevention CKD CVD highlight need optimal strategy volume management CKD patients clinical practice turn Patients CKD frequently salt sensitive The potential consequences high dietary salt intake including ﬂuid retention higher BP common context CKD When subjected volume overload left ventricular chamber dilates remodels eccentric manner In contrast concentric remodeling considered early stage cardiac adaptation increased workload13 Left ventricular hypertrophy important risk factor adverse cardiovascular outcomes patients CKD1415 Eccentric left ventricular hypertrophy associated poorer prognosis concentric hypertrophy16 indicating volume overload particular relevance pathogenesis CVD patients Furthermore elevated right left ventricular enddiastolic pressure ﬂuid retention ultimately lead increased renal venous pres sure17 Hemodynamically increase renal venous pressure results decreased renal perfusion initiates vicious circle causing sodium retention expansion plasma volume worsening renal function18 Until recently thought effect salt renal cardiovascular outcomes driven primarily changes BP However results study showed CKD patients volume overload increased risk adverse renal cardiovascular outcomes independently presence absence hypertension The risk signiﬁcantly different hypertensives nonhyper In addition study tensives volume overload CKD rats receiving highsalt diet determined proteinuria substantially changes proteinuria independent SBP changes suggesting harmful renal effects dietary sodium effects elevated systemic BP Vogt et al determined changes proteinuria sodium BPlowering effect restriction independent increased However DOI 101161JAHA115001918 Journal American Heart Association 6 Volume Overload CKD Outcomes Hung et al O R I G I N A L R E S E A R C H A B Figure 1 Relationship relative overhydration OH systolic blood pressure SBP The patients classiﬁed 4 groups according baseline SBP 140 140 mm Hg OH 7 7 suggesting relationship sodium intake proteinuria driven changes glomerular structure function19 Vegter et al conducted post hoc analysis ﬁrst second Ramipril Efﬁcacy Nephropathy trials evaluate association sodium intake proteinuria progression ESRD 500 CKD patients diabetes receiving ramipril therapy20 In study showed high dietary salt appears blunt antiproteinuric effect ACE inhibitor increase risk ESRD independent BP control In recent study enrolling prospective cohort 328 CKD patients maintenance hemodialysis demonstrated inverse association aldosterone CVD events confounding effect volume overload21 Our ﬁndings agreement previous evidence suggest treatment renin angiotensin blockers lead improved CVD outcomes CKD patients achieved In ﬁrst doubleblind randomized strict volume control controlled trial assessing effect salt restriction BP proteinuria hypertensive patients CKD stage 3 4 McMahon et al determined sodium restriction reduced extracellular volume BP proteinuria signiﬁcant adverse effects short 2week intervention22 These Figure 2 KaplanMeier survival curve renal A cardio vascular B outcomes The patients classiﬁed 4 groups according baseline systolic blood pressure SBP 140 140 mm Hg overhydration OH 7 7 The patients volume overload demonstrated substantially increased risk compared volume overload ﬁndings suggest patients CKD particularly susceptible detrimental effects saltinduced ﬂuid retention provide evidence support salt restriction volume control CKD toxicity act The detrimental effects excess salt intake occur ﬂuid retention hypertension nonvolume nonpressure pathways Recent research indicates mediators endothelial activation proinﬂammatory cytokines play pronounced role previously thought Despite interaction salt independently different pathophysiological mechanisms target organ Circumferential stretch venous endothelial cells venous congestion induces proinﬂammatory endo thelial activation23 In present study patients animals volume overload signiﬁcantly higher proinﬂammatory cytokines IL6 TNFa compared patients animals volume overload Accumulating evidence shown inﬂammation affcts myocardial renal function contributes development CVD progression CKD DOI 101161JAHA115001918 Journal American Heart Association 7 O R I G I N A L R E S E A R C H Volume Overload CKD Outcomes Hung et al Table 4 HRs Renal Cardiovascular Outcomes According Presence Absence Hypertension SBP 140 140 mm Hg Volume Overload OH 7 7 Unadjusted HR 95 CI Model 1 HR 95 CI Model 2 HR 95 CI Model 3 HR 95 CI Primary outcome eGFR decline 50 chronic dialysis SBP 140 OH 7 SBP 140 OH 7 SBP 140 OH 7 SBP 140 OH 7 10 10 10 10 110 046 262 107 044 256 094 036 248 092 036 237 294 153 567 595 329 1074 309 159 598 612 338 1109 252 126 500 494 224 1087 194 095 394 282 129 614 Secondary outcome cardiovascular morbidity mortality SBP 140 OH 7 SBP 140 OH 7 SBP 140 OH 7 SBP 140 OH 7 10 10 10 10 482 094 2484 1498 347 6465 1444 339 6145 411 080 2120 1363 315 5897 1348 317 5736 289 050 1659 323 058 1811 730 165 3230 581 127 2647 738 147 3705 520 104 2606 Model 1 adjusted age sex Model 2 adjusted model 1 variables cardiovascular disease diabetes mellitus SBP use angiotensinconverting enzyme inhibitorsangiotensin II receptor blockers Model 3 adjusted model 2 variables eGFR urine proteincreatinine ratio cutoff value 05 eGFR indicates estimated glomerular ﬁltration rate HR hazard ratio OH overhydration SBP systolic blood pressure P005 P0001 A D B E C F Figure 3 Metabolic caging studies rats baseline 4 weeks normal highsalt diets A Changes water intake B urine volume C urine sodium D ratio extracellular water total body water ECWTBW E systolic blood pressure SBP F urine proteincreatinine ratio UPCR N8 group P0001 vs ShamNS UNXNS P0001 vs ShamNS UNXNS A B P0001 vs ShamNS UNXNS UNXHS P0001 vs ShamNS ShamHS UNXNS P0001 vs ShamNS UNXNS UNXHS C P0001 vs ShamNS ShamHS UNXNS P0001 vs UNXHS D F 2way ANOVA Bonferronis posthoc tests IDP indicates indapamide ShamHS shamoperated rats raised high salt diet ShamNS shamoperated rats raised normal diet UNXHS uninephrectomized rats raised high salt diet UNXNS uninephrectomized rats raised normal diet DOI 101161JAHA115001918 Journal American Heart Association 8 O R I G I N A L R E S E A R C H Volume Overload CKD Outcomes Hung et al Table 5 Results Animal Study 4 Weeks Water intake mLd Food intake gd Body weight g Urine volume mLd Urine Na mmolL ECW L TBW L ECWTBW SBP mm Hg UPCR gg Serum TNFa pgmL Renal TNFa pglg ShamNS n8 607cid352 306cid331 3109cid3232 244cid355 95cid342 0067cid30010 0186cid30023 374cid309 101cid33 285cid3067 678cid3108 302cid3040 ShamHS n8 1719cid3244 315cid327 2572cid3111 1226cid3153 320cid316 0067cid30008 0178cid30022 375cid307 102cid34 275cid3091 740cid3234 382cid3056 UNXNS n8 656cid356 303cid316 2888cid3446 300cid347 105cid39 0070cid30010 0188cid30030 372cid310 98cid35 297cid3112 1088cid3279 300cid3032 UNXHS n8 1926cid3498 322cid343 2675cid3274 1417cid3382 251cid326 0065cid30009 0163cid30021 403cid309 134cid311 508cid3131 1780cid3704 601cid3392 UNXHSIDP n8 1720cid3298 312cid323 3054cid3222 1301cid3218 320cid371 0072cid30009 0195cid30022 373cid312 102cid36 186cid3047 1046cid3255 304cid3069 ECW indicates extracellular water SBP systolic blood pressure ShamNS shamoperated rats raised normalsalt diet ShamHS shamoperated rats raised highsalt diet TBW total body water TNFa tumor necrosis factor UNXNS uninephrectomized rats raised normalsalt diet UNXHS uninephrectomized rats raised high salt diet UNXHSIDP indapamidetreated UNXHS rats UPCR urine proteincreatinine ratio Excess sodium direct toxic effects blood vessels mediating factors oxidative stress inﬂammation endothelial cell dysfunction24 Dietary salt facilitating glomerular cardiac expression transforming growth factor b directly promote development glomerulosclerosis cardiac interstitial ﬁbrosis25 Additionally 2 recent studies demonstrated increased sodium concentrations dramatically boost induction murine human Th17 cells vitro26 High salt conditions activate p38MAPK pathway involves serum glucocorticoid kinase 1 cytokineinduced Th17 polarization Pathogenic Th17 cells highly proin ﬂammatory cells shown mediate human experimental renal diseases27 Th17 effector cells directly inﬂammation activating neutrophils induce renal participating macrophagemediated tissue injury Therefore A B Figure 4 Systemic renal inﬂammation rats 4 weeks normal highsalt diets A Tumor necrosis factora TNFa level serum N8 group P001 vs ShamNS ShamHS UNXNS P001 vs UNXHS B TNFa level kidney homogenate N8 group P005 vs ShamNS UNXNS P005 vs UNXHS 1way ANOVA Tukeys posthoc tests ANOVA indicates analysis variance IDP indapamide ShamHS shamoperated rats raised high salt diet ShamNS shamoperated rats raised normal diet UNXHS uninephrectomized rats raised high salt diet UNXNS uninephrectomized rats raised normal diet DOI 101161JAHA115001918 Journal American Heart Association 9 O R I G I N A L R E S E A R C H Volume Overload CKD Outcomes Hung et al A ShamNS ShamHS UNXNS UNXHS UNXHSIDP C ShamNS ShamHS UNXNS UNXHS UNXHSIDP E ShamNS ShamHS UNXNS UNXHS UNXHSIDP B D F Figure 5 Renal cardiac histology rats 4 weeks normal highsalt diets A Representative microphotographs immunohistochemistry ED1 renal cortex B Quantitative ED1positive macrophage inﬁltration number positive cells high power ﬁeld Signiﬁcantly greater macrophage inﬁltrations elicited UNXHS rats C Representative microphotographs PAS staining renal cortex D Quantitative analysis collagen deposition stained area glomeruli Signiﬁcantly greater glomerular damage elicited UNXHS rats E Representative microphotographs Masson staining heart F Quantitative analysis collagen deposition stained area cardiac tissue Signiﬁcantly greater cardiac interstitial ﬁbrosis elicited UNXHS rats P005 vs ShamNS ShamHS UNXNS P005 vs UNXHS 1way ANOVA Tukeys posthoc tests Magniﬁcation 9400 ANOVA indicates analysis variance IDP indapamide PAS periodic acidSchiff ShamHS shamoperated rats raised high salt diet ShamNS shamoperated rats raised normal diet UNXHS uninephrectomized rats raised high salt diet UNXNS uninephrectomized rats raised normal diet DOI 101161JAHA115001918 Journal American Heart Association 10 Volume Overload CKD Outcomes Hung et al increased dietary salt intake represent environmen tal risk factor development CKD induction pathogenic Th17 cells Study Limitations A strength study combined use prospective cohort study animal study However certain limitations study acknowledged As case observational study unable establish causality relationship volume overload outcomes Although results animal study supported hypothesis saltinduced volume overload result renal cardiovascular damage difﬁcult untangle complex relationship salt volume It unclear relationship involved salt toxicity adverse effects ﬂuid retention Another limitation lack data dietary salt ﬂuid intake CKD patients As shown Table 1 113 334 study participants receiving diuretic treatment Twentyfour hour urinary sodium excretion good proxy salt intake steady state falsely elevated patients taking diuretic Furthermore patients diuretic therapy different levels hydration status course day room misinterpretation hydration status patients Finally overall CVD event rate low present study reﬂected relatively wide CI secondary end point Although CKD patients Western countries frequently die CVD developing ESRD CKD patients Taiwan likely develop ESRD cardiovascular event28 The limited number CVD events limits ability adjust potentially important covariates Conclusions Volume overload exhibits strong association CKD progression CVD morbidity mortality patients stage 3 5 CKD In animal models CKD saltinduced ﬂuid retention results renal cardiovascular damage ameliorated diuretics Therefore ﬁndings suggest volume overload important mechanism contributing adverse outcomes observed CKD requires appropriate management Further research warranted clarify correction volume overload main targets achieve better outcomes patients CKD Sources Funding This work supported grants National Science Council NSC 992314B010004MY3 NSC 102 2314B010004MY3 NSC 1022314B303003 MOST 103 2314B303005MY2 Taipei Tzu Chi Hospital TCRDTPE NSC10208 TCRDTPE103RT4 Taipei Veterans General Hospital V102C143 V103C001 Ministry Education Aim Top University Plan Taiwan O R I G I N A L R E S E A R C H Disclosures None References 1 Levey AS Atkins R Coresh J Cohen EP Collins AJ Eckardt KU Nahas ME Jaber BL Jadoul M Levin A Powe NR Rossert J Wheeler DC Lameire N Eknoyan G Chronic kidney disease global public health problem approaches initiativesa position statement Kidney Disease Improving Global Outcomes Kidney Int 200772247259 2 Wen CP Cheng TY Tsai MK Chang YC Chan HT Tsai SP Chiang PH Hsu CC Sung PK Hsu YH Wen SF Allcause mortality attributable chronic kidney disease prospective cohort study based 462293 adults Taiwan Lancet 200837121732182 3 Hsu TW Liu JS Hung SC Kuo KL Chang YK Chen YC Hsu CC Tarng DC Renoprotective effect reninangiotensin blockade advanced chronic kidney disease nondialyzed patients hypertension anemia JAMA Intern Med 2014174347354 4 Chen YR Yang Y Wang SC Chiu PF Chou WY Lin CY Chang JM Chen TW Ferng SH Lin CL Effectiveness multidisciplinary care chronic kidney disease Taiwan 3year prospective cohort study Nephrol Dial Transplant 201328671682 5 Hung SC Kuo KL Peng CH Wu CH Wang YC Tarng DC Association ﬂuid retention anemia clinical outcomes patients chronic J Am Heart Assoc 20154e001480 doi 101161JAHA kidney disease 114001480 6 Hung SC Kuo KL Peng CH Wu CH Lien YC Wang YC Tarng DC Volume overload correlates cardiovascular risk factors patients chronic kidney disease Kidney Int 201485703709 7 KalantarZadeh K Regidor DL Kovesdy CP Van Wyck D Bunnapradist S Horwich TB Fonarow GC Fluid retention associated cardiovascular patients undergoing longterm hemodialysis Circulation mortality 2009119671679 8 Bouchard J Soroko SB Chertow GM Himmelfarb J Ikizler TA Paganini EP Mehta RL Fluid accumulation survival recovery kidney function critically ill patients acute kidney injury Kidney Int 200976422427 9 Tsai YC Tsai JC Chen SC Chiu YW Hwang SJ Hung CC Chen TH Kuo MC Chen HC Association ﬂuid overload kidney disease progression advanced CKD prospective cohort study Am J Kidney Dis 2014636875 10 Chamney PW Wabel P Moissl UM Muller MJ BosyWestphal A Korth O Fuller NJ A wholebody model distinguish excess ﬂuid hydration major body tissues Am J Clin Nutr 2007858089 11 Wieskotten S Heinke S Wabel P Moissl U Becker J Pirlich M Keymling M Isermann R Bioimpedancebased identiﬁcation malnutrition fuzzy logic Physiol Meas 200829639654 12 Laupacis A Sekar N Stiell IG Clinical prediction rules A review suggested modiﬁcations methodological standards JAMA 1997277488494 13 Selvetella G Lembo G Mechanisms cardiac hypertrophy Heart Fail Clin 20051263273 14 Schiffrin EL Lipman ML Mann JF Chronic kidney disease effects cardiovascular Circulation 20071168597 15 Essig M Escoubet B Zuttere D Blanchet F Arnoult F Dupuis E Michel C Mignon F Mentre F Clerici C Vrtovsnik F Cardiovascular remodelling extracellular ﬂuid excess early stages chronic kidney disease Nephrol Dial Transplant 200823239248 16 Levin A Singer J Thompson CR Ross H Lewis M Prevalent left ventricular identifying opportunities hypertrophy predialysis population intervention Am J Kidney Dis 199627347354 17 Sarraf M Masoumi A Schrier RW Cardiorenal syndrome acute decompen sated heart failure Clin J Am Soc Nephrol 2009420132026 18 Firth JD Raine AE Ledingham JG Raised venous pressure direct cause renal sodium retention oedema Lancet 1998110331035 DOI 101161JAHA115001918 Journal American Heart Association 11 Volume Overload CKD Outcomes Hung et al 19 Vogt L Waanders F Boomsma F Zeeuw D Navis G Effects dietary sodium hydrochlorothiazide antiproteinuric efﬁcacy losartan J Am Soc Nephrol 2008199991007 24 AlSolaiman Y Jesri A Zhao Y Morrow JD Egan BM Lowsodium DASH reduces oxidative stress improves vascular function saltsensitive humans J Hum Hypertens 200923826835 20 Vegter S Perna A Postma MJ Navis G Remuzzi G Ruggenenti P Sodium J Am Soc Nephrol intake ACE inhibition progression ESRD 201223165173 21 Hung SC Lin YP Huang HL Pu HF Tarng DC Aldosterone mortality hemodialysis patients role volume overload PLoS One 20138e57511 22 McMahon EJ Bauer JD Hawley CM Isbel NM Stowasser M Johnson DW Campbell KL A randomized trial dietary sodium restriction CKD J Am Soc Nephrol 20132420962103 23 Gnanaraj JF von Haehling S Anker SD Raj DS Radhakrishnan J The relevance congestion cardiorenal syndrome Kidney Int 201383384391 25 Ying WZ Sanders PW Dietary salt modulates renal production transforming growth factorb rats Am J Physiol Renal Physiol 1998274F635F641 26 Wu C Yosef N Thalhamer T Zhu C Xiao S Kishi Y Regev A Kuchroo VK Induction pathogenic TH17 cells inducible saltsensing kinase SGK1 Nature 2013496513517 27 Kitching AR Holdsworth SR The emergence TH17 cells effectors renal injury J Am Soc Nephrol 201122235238 28 Chiu YL Chien KL Lin SL Chen YM Tsai TJ Wu KD Outcomes stage 35 chronic kidney disease endstage renal disease single center Taiwan Nephron Clin Pract 2008109c109c118 O R I G I N A L R E S E A R C H DOI 101161JAHA115001918 Journal American Heart Association 12